Literature DB >> 31573628

Drive Times to Opioid Treatment Programs in Urban and Rural Counties in 5 US States.

Paul J Joudrey1, E Jennifer Edelman2, Emily A Wang2.   

Abstract

Mesh:

Substances:

Year:  2019        PMID: 31573628      PMCID: PMC6777265          DOI: 10.1001/jama.2019.12562

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Special treatment--the story of Medicare's ESRD entitlement.

Authors:  Richard A Rettig
Journal:  N Engl J Med       Date:  2011-02-17       Impact factor: 91.245

2.  Trends and Patterns of Geographic Variation in Mortality From Substance Use Disorders and Intentional Injuries Among US Counties, 1980-2014.

Authors:  Laura Dwyer-Lindgren; Amelia Bertozzi-Villa; Rebecca W Stubbs; Chloe Morozoff; Shreya Shirude; Jürgen Unützer; Mohsen Naghavi; Ali H Mokdad; Christopher J L Murray
Journal:  JAMA       Date:  2018-03-13       Impact factor: 56.272

3.  A call for evidence-based medical treatment of opioid dependence in the United States and Canada.

Authors:  Bohdan Nosyk; M Douglas Anglin; Suzanne Brissette; Thomas Kerr; David C Marsh; Bruce R Schackman; Evan Wood; Julio S G Montaner
Journal:  Health Aff (Millwood)       Date:  2013-08       Impact factor: 6.301

4.  Comparing alternative approaches to measuring the geographical accessibility of urban health services: Distance types and aggregation-error issues.

Authors:  Philippe Apparicio; Mohamed Abdelmajid; Mylène Riva; Richard Shearmur
Journal:  Int J Health Geogr       Date:  2008-02-18       Impact factor: 3.918

  4 in total
  25 in total

Review 1.  The American Opioid Epidemic in Special Populations: Five Examples.

Authors:  Carlos Blanco; Mir M Ali; Aaron Beswick; Karen Drexler; Cheri Hoffman; Christopher M Jones; Tisha R A Wiley; Allan Coukell
Journal:  NAM Perspect       Date:  2020-10-26

2.  Population-based estimates of geographic accessibility of medication for opioid use disorder by substance use disorder treatment facilities from 2014 to 2020.

Authors:  Jonathan Cantor; David Powell; Aaron Kofner; Bradley D Stein
Journal:  Drug Alcohol Depend       Date:  2021-09-27       Impact factor: 4.492

3.  Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study.

Authors:  Paul J Joudrey; Nicholas Chadi; Payel Roy; Kenneth L Morford; Paxton Bach; Simeon Kimmel; Emily A Wang; Susan L Calcaterra
Journal:  Drug Alcohol Depend       Date:  2020-03-27       Impact factor: 4.492

4.  Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky.

Authors:  Hannah Lf Cooper; David H Cloud; Patricia R Freeman; Monica Fadanelli; Travis Green; Connor Van Meter; Stephanie Beane; Umedjon Ibragimov; April M Young
Journal:  Int J Drug Policy       Date:  2020-03-26

5.  Racial/Ethnic Differences in the Medical Treatment of Opioid Use Disorders Within the VA Healthcare System Following Non-Fatal Opioid Overdose.

Authors:  Utibe R Essien; Florentina E Sileanu; Xinhua Zhao; Jane M Liebschutz; Carolyn T Thorpe; Chester B Good; Maria K Mor; Thomas R Radomski; Leslie R M Hausmann; Michael J Fine; Walid F Gellad
Journal:  J Gen Intern Med       Date:  2020-01-21       Impact factor: 5.128

Review 6.  Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.

Authors:  Reda M Chalhoub; Peter W Kalivas
Journal:  Drugs       Date:  2020-10       Impact factor: 9.546

7.  Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study.

Authors:  Alexandria Macmadu; Kimberly Paull; Rouba Youssef; Sivakumar Batthala; Kevin H Wilson; Elizabeth A Samuels; Jesse L Yedinak; Brandon D L Marshall
Journal:  Drug Alcohol Depend       Date:  2020-11-23       Impact factor: 4.492

8.  Expanding access to methadone treatment in Ohio through federally qualified health centers and a chain pharmacy: A geospatial modeling analysis.

Authors:  Suzan Iloglu; Paul J Joudrey; Emily A Wang; Thomas A Thornhill; Gregg Gonsalves
Journal:  Drug Alcohol Depend       Date:  2021-01-19       Impact factor: 4.492

9.  Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Center for Clinical Trials Network Task Force report.

Authors:  Paul J Joudrey; Gavin Bart; Robert K Brooner; Lawrence Brown; Julie Dickson-Gomez; Adam Gordon; Sarah S Kawasaki; Jane M Liebschutz; Edward Nunes; Dennis McCarty; Robert P Schwartz; José Szapocnik; Madhukar Trivedi; Judith I Tsui; Arthur Williams; Li-Tzy Wu; David A Fiellin
Journal:  Subst Abus       Date:  2021       Impact factor: 3.716

10.  A Vulnerability Assessment for a Future HIV Outbreak Associated With Injection Drug Use in Illinois, 2017-2018.

Authors:  Cara Jane Bergo; Jennifer R Epstein; Stacey Hoferka; Marynia Aniela Kolak; Mai T Pho
Journal:  Front Sociol       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.